HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lawson, W. E. Articles by Loyd, J. E. Search for Related Content PubMed PubMed Citation Articles by Lawson, W. E. Articles by Loyd, J. E.

The Genetic Approach in Pulmonary Fibrosis

Can It Provide Clues to This Complex Disease?

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine; and Department of Veterans Affairs Medical Center, Nashville, Tennessee

Correspondence and requests for reprints should be addressed to James E. Loyd, M.D., Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, T-1217 MCN, Nashville, TN 37232-2650. E-mail: jim.loyd{at}vanderbilt.edu

ABSTRACT

Multiple investigators have undertaken genetic studies in idiopathic pulmonary fibrosis populations in attempts to define genetic links to disease in hopes that this would improve understanding of disease pathogenesis and target pathways for therapy. Multiple genes have been evaluated using a candidate gene approach with limited success, with results suggesting a disease modifier effect rather than a disease causing effect. Using this approach, associations have been observed between idiopathic pulmonary fibrosis and specific polymorphisms in genes encoding interleukin-1 receptor antagonist, tumor necrosis factor-, and complement receptor 1. Recently investigators have used familial pulmonary fibrosis cohorts to evaluate for genetic mutations associated with idiopathic pulmonary fibrosis. Using one pulmonary fibrosis kindred, a mutation in the gene encoding surfactant protein C was identified as the cause of pulmonary fibrosis in this family. Subsequently, another individual with idiopathic pulmonary fibrosis was identified with a different mutation in surfactant protein C. Though rarely found in patients with idiopathic pulmonary fibrosis, these surfactant protein C mutations highlight the importance of the alveolar epithelium in disease pathogenesis. A recent collaboration between investigators at three major centers has resulted in the largest collection of families with pulmonary fibrosis to date, with hopes that this effort will identify genetic mutations associated with idiopathic pulmonary fibrosis. If genetic links to idiopathic pulmonary fibrosis are defined in this study, then the pathways involved with these genes and gene products can be targeted by investigators to help identify potential treatment options for this disease.

Key Words: familial pulmonary fibrosis • idiopathic pulmonary fibrosis • surfactant protein C

This article has been cited by other articles:

				J. E. Loyd Gene expression profiling: can we identify the right target genes? Eur. Respir. Rev., December 1, 2008; 17(109): 163 - 167. [Abstract] [Full Text] [PDF]

				R. M. Jackson and C. D. Fell Etanercept for Idiopathic Pulmonary Fibrosis: Lessons on Clinical Trial Design Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 889 - 891. [Full Text] [PDF]

				W. E. Lawson, P. F. Crossno, V. V. Polosukhin, J. Roldan, D.-S. Cheng, K. B. Lane, T. R. Blackwell, C. Xu, C. Markin, L. B. Ware, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1119 - L1126. [Abstract] [Full Text] [PDF]

				T. M. Maher, A. U. Wells, and G. J. Laurent Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur. Respir. J., November 1, 2007; 30(5): 835 - 839. [Abstract] [Full Text] [PDF]

				H. R. Collard, B. B. Moore, K. R. Flaherty, K. K. Brown, R. J. Kaner, T. E. King Jr., J. A. Lasky, J. E. Loyd, I. Noth, M. A. Olman, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 636 - 643. [Abstract] [Full Text] [PDF]

				M. Y. Armanios, J. J.-L. Chen, J. D. Cogan, J. K. Alder, R. G. Ingersoll, C. Markin, W. E. Lawson, M. Xie, I. Vulto, J. A. Phillips III, et al. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis N. Engl. J. Med., March 29, 2007; 356(13): 1317 - 1326. [Abstract] [Full Text] [PDF]

				S. M. Studer and N. Kaminski Towards Systems Biology of Human Pulmonary Fibrosis Proceedings of the ATS, January 1, 2007; 4(1): 85 - 91. [Abstract] [Full Text] [PDF]